# Individualized Homeopathic Treatment for Persistent Insomnia and Generalized Anxiety Disorder: A Case Report

**Authors:** Jacqueline Soto-Sánchez, Gilberto Garza-Treviño

PMC · DOI: 10.7759/cureus.67203 · 2024-08-19

## TL;DR

A 27-year-old man with insomnia and anxiety showed significant improvement after four months of individualized homeopathic treatment, with effects lasting a year.

## Contribution

This case report provides preliminary evidence that individualized homeopathy may be effective for persistent insomnia and comorbid GAD.

## Key findings

- The patient experienced reduced insomnia and anxiety symptoms after four months of homeopathic treatment.
- Improvements persisted for one year even after discontinuing all conventional medications.
- The case suggests individualized homeopathy could be a viable treatment option for comorbid insomnia and GAD.

## Abstract

Insomnia is a widespread disease that tends to be associated with other problems, like anxiety. The most frequent anxiety disorder is generalized anxiety disorder (GAD), which is characterized by excessive worrying about everyday situations. Medications for insomnia and anxiety can have adverse reactions and the latter may be ineffective in up to 30% of patients. Here we present a case report of a 27-year-old male patient who suffered from persistent insomnia with comorbid GAD and schizophreniform disorder. Initially, he was taking alprazolam, paroxetine, and risperidone, which had a less-than-satisfactory effect. He was treated with individualized homeopathy, which produced a remarkable improvement within four months. This was evidenced by a decrease in difficulty falling asleep and daytime sleepiness; in addition, anxiety and its accompanying symptoms, such as irritability and diaphoresis, were reduced. This improvement persists for up to one year after the commencement of treatment and despite discontinuation of all medications. This clinical report provides preliminary evidence that persistent insomnia and comorbid GAD can be treated successfully with individualized homeopathy. However, further randomized controlled studies are needed to evaluate its efficacy, effectiveness, and safety more conclusively.

## Linked entities

- **Chemicals:** alprazolam (PubChem CID 2118), paroxetine (PubChem CID 43815), risperidone (PubChem CID 5073)
- **Diseases:** insomnia (MONDO:0013600), generalized anxiety disorder (MONDO:0001942), schizophreniform disorder (MONDO:0001265)

## Full-text entities

- **Diseases:** falling asleep (MESH:C537863), Insomnia (MESH:D007319), GAD (MESH:C000726808), schizophreniform disorder (MESH:D011618), irritability (MESH:D001523), anxiety disorder (MESH:D001008), anxiety (MESH:D001007), daytime sleepiness (MESH:D012893)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11409940/full.md

---
Source: https://tomesphere.com/paper/PMC11409940